Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level

This research will employ cross-sectional analytical to determine diagnostic accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the evaluation of Recurrent Papillary Thyroid Carcinoma with patient's raised Thyroglobulin level in Lahore.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Papillary Thyroid Carcinoma Adenocarcinoma Adenocarcinoma, Papillary Carcinoma Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial Thyroid Cancer, Papillary Thyroid Diseases Thyroid Neoplasms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

INMOL hospital

Lahore, Punjab Province, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients include both male and female from 18years to 80years
Patients presented with raised thyroglobulin
Patients with suspected diagnosis of recurrent papillary thyroid carcinoma

Exclusion criteria

Patients exclude both male and female below 18years and above 80years
All the patients presented with carcinoma other than papillary carcinoma.
All the patients with normal thyroglobulin level.

Treatment and study plan

Primary outcomes

Nominal self admsinitered questioner

Time frame: 12 Months

Scoring in a nominal scale involves assigning a unique numerical or symbolic code to each category. For instance, in a gender survey, you might code male as "1" and female as "2." However, these codes are purely for identification and do not imply any order or magnitude

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

Diagnostic Accuracy of Flourodeoxyglucose-18 Positron Emission Computed Tomography in the Evaluation of Recurrent Papillary Thyroid Carcinoma With Patient's Raised Thyroglobulin Level in Lahore

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2026
First posted: Jul 14, 2025
Registry last updated: Jul 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, Not Recruiting